메뉴 건너뛰기




Volumn 167, Issue 2, 2003, Pages 167-173

Essential conservation of D1 mutant phenotype at the level of individual topographies of behaviour in mice lacking both D1 and D3 dopamine receptors

Author keywords

Behavioural topography; D1 dopamine receptor; D1 D3 double knockout; D3 dopamine receptor; Ethological assessment; Gene targeting

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 2 RECEPTOR; DRD3 PROTEIN, MOUSE;

EID: 0038355301     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1415-0     Document Type: Article
Times cited : (16)

References (37)
  • 8
    • 0033523043 scopus 로고    scopus 로고
    • Genetics of mouse behaviour: Interactions with laboratory environment
    • Crabbe JC, Wahlsten D, Dudek BC (1999) Genetics of mouse behaviour: interactions with laboratory environment. Science 284:1670-1673
    • (1999) Science , vol.284 , pp. 1670-1673
    • Crabbe, J.C.1    Wahlsten, D.2    Dudek, B.C.3
  • 10
    • 0031827655 scopus 로고    scopus 로고
    • Dopamine receptors and dopamine transporter in brain function and addictive behaviours: Insights from targeted mouse mutants
    • Drago J, Padungchaichot P, Accili D, Fuchs S (1998) Dopamine receptors and dopamine transporter in brain function and addictive behaviours: insights from targeted mouse mutants. Dev Neurosci 20:188-203
    • (1998) Dev Neurosci , vol.20 , pp. 188-203
    • Drago, J.1    Padungchaichot, P.2    Accili, D.3    Fuchs, S.4
  • 11
    • 0030897476 scopus 로고    scopus 로고
    • PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease
    • Ginovart N, Lundin A, Farde L, Halldin C, Backman L, Swahn CG, Pauli S, Sedvall G (1997) PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Brain 120:503-514
    • (1997) Brain , vol.120 , pp. 503-514
    • Ginovart, N.1    Lundin, A.2    Farde, L.3    Halldin, C.4    Backman, L.5    Swahn, C.G.6    Pauli, S.7    Sedvall, G.8
  • 13
    • 0013920522 scopus 로고
    • Dopamine (3-hydroxytyramine) and brain function
    • Hornykiewicz O (1966) Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 18:925-964
    • (1966) Pharmacol Rev , vol.18 , pp. 925-964
    • Hornykiewicz, O.1
  • 15
    • 0034617405 scopus 로고    scopus 로고
    • Modification of dopamine D(1) receptor knockout phenotype in mice lacking both dopamine D(1) and D(3) receptors
    • Karasinska JM, George SR, El-Ghundi M, Fletcher PJ, O'Dowd BF (2000) Modification of dopamine D(1) receptor knockout phenotype in mice lacking both dopamine D(1) and D(3) receptors. Eur J Pharmacol 399:171-181
    • (2000) Eur J Pharmacol , vol.399 , pp. 171-181
    • Karasinska, J.M.1    George, S.R.2    El-Ghundi, M.3    Fletcher, P.J.4    O'Dowd, B.F.5
  • 21
    • 0029835948 scopus 로고    scopus 로고
    • Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome
    • Peterson BS (1996) Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome. J Clin Psychiatry 57:24-34
    • (1996) J Clin Psychiatry , vol.57 , pp. 24-34
    • Peterson, B.S.1
  • 26
    • 0032900952 scopus 로고    scopus 로고
    • New insights into dopaminergic receptor function using antisense and genetically altered animals
    • Sibley DR (1999) New insights into dopaminergic receptor function using antisense and genetically altered animals. Annu Rev Pharmacol Toxicol 39:313-341
    • (1999) Annu Rev Pharmacol Toxicol , vol.39 , pp. 313-341
    • Sibley, D.R.1
  • 27
    • 0030608822 scopus 로고    scopus 로고
    • 3 dopamine receptor-deficient mouse: Evidence for reduced anxiety
    • 3 dopamine receptor-deficient mouse: evidence for reduced anxiety. Physiol Behav 63:137-141
    • (1998) Physiol Behav , vol.63 , pp. 137-141
    • Steiner, H.1    Fuchs, S.2    Accili, D.3
  • 29
    • 0024839270 scopus 로고
    • Schizophrenia, affective psychoses, and other disorders treated with neuroleptic drugs: The enigma of tardive dyskinesia, its neurobiological determinants, and the conflict of paradigms
    • Waddington JL (1989) Schizophrenia, affective psychoses, and other disorders treated with neuroleptic drugs: the enigma of tardive dyskinesia, its neurobiological determinants, and the conflict of paradigms. Int Rev Neurobiol 31:297-353
    • (1989) Int Rev Neurobiol , vol.31 , pp. 297-353
    • Waddington, J.L.1
  • 33
    • 0035042853 scopus 로고    scopus 로고
    • The psychopharmacology-molecular biology interface: Exploring the behavioural roles of dopamine receptor subtypes using targeted gene deletion ("knockout")
    • Waddington JL, Clifford JJ, McNamara FN, Tomiyama K, Koshikawa N, Croke DT (2001) The psychopharmacology-molecular biology interface: exploring the behavioural roles of dopamine receptor subtypes using targeted gene deletion ("knockout"). Prog Neuropsychopharmacol Biol Psychiatry 25:925-964
    • (2001) Prog Neuropsychopharmacol Biol Psychiatry , vol.25 , pp. 925-964
    • Waddington, J.L.1    Clifford, J.J.2    McNamara, F.N.3    Tomiyama, K.4    Koshikawa, N.5    Croke, D.T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.